Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cannabidiol for GVHD Prophylaxis in Allogeneic Stem Cell Transplantation
NCT01385124Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Sep 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in graft-versus-host disease (GVHD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01385124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01385124.